Home › Funds › WEXFORD CAPITAL LP › STIM

WEXFORD CAPITAL LP position in STIM

NEURONETICS INC · Health Care

WEXFORD CAPITAL LP reported holding 2,002,625 shares of STIM (NEURONETICS INC) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.61% of its reported portfolio and ranking #25 among its reported holdings. WEXFORD CAPITAL LP has disclosed STIM holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)2.00M sh
Reported value held$4.69M
Portfolio Weight0.61%
First reportedQ1 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How WEXFORD CAPITAL LP's STIM position evolved

WEXFORD CAPITAL LP first disclosed a stake in STIM in Q1 2025 at 471,725 shares (US$1.7M). The position peaked in Q3 2026 at 2,002,625 shares, worth US$4.7M. Across 7 filings, WEXFORD CAPITAL LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,002,625 shares valued at US$4.7M. Notable position changes include a 83% increase in Q3 2025 (shares fell 49% over the following quarter), a 45% trim in Q4 2025 (shares rose 5% over the following quarter), a 186% increase in Q2 2026 (shares rose 80% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 471.73K $1.74M New
Q2 2025 643.07K $2.24M Add
Q3 2025 1.18M $3.21M Add
Q4 2025 644.95K $890.03K Reduce
Q1 2026 700.96K $1.02M Add
Q2 2026 2.00M $2.60M Add
Q3 2026 2.00M $4.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STIM and 13F data

STIM (NEURONETICS INC) is a Health Care company. 28 other funds we track also report a position in STIM — the largest reported positions include Madryn Asset Management, LP (US$43.4M), Lane Generational LLC (US$3.0M), FourWorld Capital Management LLC (US$2.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STIM

All STIM fund holders →

FAQ

How long has WEXFORD CAPITAL LP held STIM?

WEXFORD CAPITAL LP has disclosed STIM holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is WEXFORD CAPITAL LP's current position in STIM?

As of Q3 2026, WEXFORD CAPITAL LP holds 2.00M shares of STIM (NEURONETICS INC), valued at $4.69M, representing 0.61% of its reported portfolio and ranking #25.

Has WEXFORD CAPITAL LP been buying or selling STIM?

In the latest 13F filing (Q3 2026), WEXFORD CAPITAL LP held unchanged its position in STIM. The position peaked in Q3 2026 at 2.00M shares.

Which other funds hold STIM?

Other major institutional holders of STIM include Madryn Asset Management, LP, Lane Generational LLC, FourWorld Capital Management LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.